Corrigendum: CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome (Frontiers in Immunology, (2021), 12, (633297), 10.3389/fimmu.2021.633297)

Latorre EA, Rodiguez-Reyna TS, Cervántes-Rosete D, Hernández Cárdenas CM, Khader SA, Zlotnik A and Zúñiga J (2021) CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome. Front. Immunol. 12:633297. doi: 10.3389/fimmu.2021.633297full citation of the original version of the article.An author name was incorrectly spelled as Tatiana Sofia Rodiguez-Reyna. The correct spelling is Tatiana Sofía Rodríguez-Reyna. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.In the published article, there was an error in affiliation of Criselda Mendoza-Milla. Instead of "Laboratorio de Inmunobiología y Genética, Instituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", Mexico City, Mexico", it should be "Departamento de Fibrosis Pulmonar, Instituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", Mexico City, Mexico". The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.